How to Buy Anthropic Stock: ANT Closed Day One at $97.17

Update, 19 Nov 2026, 19:15 UTC: ANT is trading

Anthropic priced its IPO at $83.00 on 18 November and its Class A shares began trading on the Nasdaq Global Select Market under the ticker ANT on 19 November, its pricing prospectus shows. The IPO allocation step is over; shares now change hands on Nasdaq.

The stock opened at $111.50, 34.3% above the IPO price, CNBC reported. At 2:14 p.m. ET it traded at $95.16, up 14.65% from $83, after a day range of $92.72 to $114.99 on about 677 million shares, Nasdaq data show. At $95.16, Anthropic is worth about $1.26 trillion on its 13.22 billion shares outstanding (our arithmetic).

Follow every move on our Anthropic IPO live blog, and see how the open priced in. This is not investment advice.

Anthropic’s shares are expected to start trading on Nasdaq under the ticker ANT on 19 November, after the price is set on 18 November, its IPO website says. Its amended IPO filing puts the range at $70.00 to $78.00 a share for 825,000,000 Class A shares.

Individual investors can ask for shares at the IPO price through six US platforms the filing names, including Fidelity, Robinhood and SoFi. Fidelity’s page sets a 25-share minimum request, $1,750 to $1,950 across the range by our arithmetic, and says its offer period closes at 4:00 PM ET on Tuesday, 17 November.

This is a guide to the mechanics, built from Anthropic’s filings and the brokers’ own pages. It is not investment advice, and we make no recommendation on whether to buy.

Important: not investment advice

This article is for information and education only. It is not investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy or sell any security, ETF, option or other financial product. FourWeekMBA is not a broker-dealer or a registered investment adviser. IPO shares, leveraged and inverse ETFs, and options carry significant risk, including the loss of your entire investment; leveraged and inverse ETFs reset daily and can lose value quickly. Prices, availability, fees and eligibility change and can differ by country and broker, so check the prospectus and your broker’s terms. Figures marked “our arithmetic” are our own calculations from the cited filings and may contain errors. Do your own research and consider speaking to a licensed financial professional before making any investment decision.

Update, 19 November 2026, 21:26 UTC: Anthropic closed day one at $97.17. ANT ended its first trading day at $97.17, up $14.17 or 17.07% from the $83 IPO price, according to Nasdaq’s official close at 4:00 p.m. ET. Bloomberg also reported the $97.17 close.

The stock opened at $111.50, CNBC reported, and traded between $92.72 and $115.10, Nasdaq data show. The close is 12.9% below the open and values Anthropic at about $1.28 trillion on the 13,219,642,276 shares outstanding in its prospectus (our arithmetic).

Our day-one close piece has the full numbers. None of this is investment advice.

Update, 18 November 2026, 17:07 UTC: an ETF named after Anthropic does not hold Anthropic. Social posts today flagged Harbor Capital’s Anthropic AI Lab Ecosystem ETF (ANTW) as a way into the IPO. Harbor’s fund page lists an inception date of 12 August 2026, a 0.59% expense ratio and $38.525 million in net assets as of 17 November. Its stated objective is exposure to “portfolio-eligible companies most directly linked to the Anthropic artificial intelligence ecosystem”. Its top ten holdings as of 16 November were TeraWulf, Alphabet, Amazon, Microsoft, Riot Platforms, Broadcom, Salesforce, SpaceX, Blackstone and AMD, together 60.0% of net assets; Anthropic is not among the holdings Harbor lists. The fund page showed a year-to-date NAV return of minus 18.88% as of 16 November. Whether the fund buys Anthropic shares after listing is not stated on the page we read. This is not investment advice.

Update, 18 November 2026, 20:09 UTC: leveraged Anthropic ETFs are filed, but none can trade before the stock does. Bloomberg reports that providers have filed for “more than 20 exchange-traded products to amplify daily moves” on Anthropic once it goes public, both up and down, citing a Bloomberg Intelligence tally, and that after SpaceX’s debut “only one” of the leveraged ETFs launched on it “managed to attract meaningful assets”. In the SEC filings we read, our count is 10 leveraged or inverse Anthropic funds: GraniteShares 2x Long and 2x Short Anthropic Daily and ProShares Ultra and UltraShort Anthropic (filed 5 November), Defiance 2X ANT Long and Short Daily (6 November), and REX and T-REX 2X Long and Inverse Anthropic Daily Target funds (4 November, 26 October). Those funds aim to hold swaps on the listed shares, so they can only start once Anthropic’s shares trade; the REX and T-REX filings are still proposed amendments. Leveraged funds reset daily and can lose much more than the stock. This is not investment advice.

What Anthropic Is Selling

Anthropic’s Amendment No. 2 to its S-1, filed on 10 November, says the company has applied to list its Class A common stock on the Nasdaq Global Select Market under the symbol “ANT.” It is selling 801,351,354 shares, and selling stockholders are selling 23,648,646, for 825,000,000 in all.

At $70, $74 and $78 that is $57.75 billion, $61.05 billion and $64.35 billion of stock, by our arithmetic. The underwriters also have an option to buy up to an additional 123,750,000 shares from Anthropic, 15% of the base deal, by our arithmetic.

The filing names Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC as the representatives of the underwriters. Separately, seven companies including Google, NVIDIA and Microsoft have agreed to buy $26.0 billion of Class N common stock in a private placement at the IPO price; those shares are not part of the public offering.

Update, 18 November 2026, 15:42 UTC: order book and possible upsizing. Anthropic is considering upsizing its IPO, people familiar with the details told CNBC on 18 November: “Institutional demand for the offering is around $400 billion, while retail demand is approaching $100 billion”. “The orders are indications of interest and are not binding”, and Anthropic is expected to set its final price after market close on Wednesday, CNBC reported. That is close to $500 billion of indicated demand, about 7.8 times the up-to-$64.35 billion base deal at $78 (our arithmetic). Our full report: Anthropic IPO Draws ~$500B of Orders, Weighs Upsizing Deal. Not investment advice.

Update, 18 November 2026, 14:33 UTC: Nasdaq has approved the listing; retail demand estimate reiterated. Nasdaq filed a certification with the SEC (form type CERT, dated 18 November 2026, filed 09:12 a.m. ET) stating that “the security described above has been approved by the Exchange for listing and registration upon official notice of issuance”; the security is “Class A common stock, $0.00001 par value per share”. Nasdaq also wrote: “We understand that the Registrant is seeking effectiveness of the Form 8 -A 12(b) concurrently with effectiveness of its 1933 Act Registration Statement, and we hereby join in such request”. Our reading: the exchange has cleared the listing, and the next step is the SEC declaring the registration statement effective; the certification itself gives no price. Separately, CNBC reported on 18 November that Vanda Research “estimates that Anthropic could see approximately $250 million of retail net buying when it starts trading Thursday, double the size of SpaceX’s IPO”, and that “Individual investors are expected to be allocated as much as 20% in that initial offering”. Not investment advice.

Update, 18 November 2026, 09:12 UTC: a second outlet says above the range. Anthropic “is likely to price its IPO above the current range of $70 to $78”, multiple sources told CNBC’s David Faber, CNBC reported on Tuesday. According to those people, Anthropic planned to close the order books and lock in total demand at 4 p.m. ET on Tuesday (21:00 UTC), and it is slated to list on the Nasdaq under the ticker ANT and start trading on 19 November, CNBC said. With the Wall Street Journal’s report below, that makes two outlets reporting a price above the range. Neither is a filed price: when we checked SEC EDGAR at 08:51 UTC on 18 November, Anthropic’s latest filing was still the 17 November Form 8-A, with no final prospectus showing an offering price. The steps below for buying on the first trading day are unchanged. Not investment advice.

Update, 17 November 2026, 18:08 UTC: above $80. The Wall Street Journal reported, citing people familiar with the matter, that Anthropic expects to price its IPO higher than planned and could price at more than $80 a share, and that its advisers have discussed a valuation of around $1.5 trillion or $1.6 trillion. On the 13,086,672,593 shares in S-1/A No. 3, $80 is $1.05 trillion, by our arithmetic; our piece sets out why the reported figures imply a different share count. Not investment advice.

Update, 17 November 2026, 13:43 UTC: Bloomberg on the pre-IPO “back doors”. Bloomberg reported on 17 November, under the headline “ETFs, Swaps, Perps Offer Back Door to Anthropic ‘Stock’ Pre-IPO”, that before the Nasdaq debut “retail traders are already finding ways to get a piece of the AI giant”. The article’s web address also names closed-end funds. We could read only the opening of the article, so we do not repeat product names or prices from it. How a pre-IPO perpetual contract prices Anthropic is in our perps explainer; the Anthropic ETFs on file and the Plus500 CFDs are in the updates below. None of these are Anthropic shares. A fund can trade above or below the value of what it holds, and a swap, CFD or perpetual contract pays on a price, depends on the broker, bank or trading venue on the other side, and gives no vote or claim on the company. This is not investment advice.

Update, 17 November 2026, 12:07 UTC: third amended prospectus, terms unchanged. Anthropic filed S-1/A No. 3 with the SEC on 17 November. The estimated price is still “between $70.00 and $78.00” a share for 825 million Class A shares, and the filing now says “We have been approved to list our Class A common stock on the Nasdaq Global Select Market under the symbol “ANT.”” Up to 315 million shares held by non-founder directors, officers, staff and consultants may become eligible for sale on the first trading day, against 316 million in the previous amendment. The filing also puts $3.5 billion and about $3.0 billion of stock-based compensation expense on RSUs at the $74 midpoint; our piece lists every change. Anthropic has not priced the offering. This is not investment advice.

Update, 17 November 2026, 08:51 UTC: Plus500 Anthropic CFDs (outside the US). Plus500, the trading platform listed in London, has an Anthropic IPO page that invites clients to “Place an order before the official debut” on Anthropic share CFDs, with “leverage up to 1:5” in the version shown to us from the UK, where Plus500CY, regulated by the Cyprus Securities and Exchange Commission, is named as “the issuer and seller”. A ratio of 1:5 is the cap that EU and UK rules set for retail CFDs on individual shares. FX News Group reported on 17 November that a pre-order is “set to execute at the first available price when the Anthropic CFD opens on 19 November”, that Plus500 will also offer a separate 24/5 Anthropic CFD after the listing, and that leverage goes “Up to 1:20, depending on the instrument and your client classification”.

What a CFD is, and is not. A CFD (contract for difference) is a leveraged derivative: a contract with the broker on the price move, not a share. In FX News Group’s words, “A pre-order does not give you an IPO allocation or ownership of Anthropic shares”, and “The execution price may differ significantly from the IPO offer price”. At 1:5, a 20% move against a position equals the whole margin put up, by our arithmetic. Plus500’s own risk warning reads: “CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider.” Whether you can trade it depends on where you live: Plus500 serves clients through subsidiaries regulated by the FCA in the UK, CySEC in Cyprus, ASIC in Australia and others. When we opened its Anthropic IPO news page from a US address, it redirected to us.plus500.com, Plus500’s US futures site; US rules bar CFDs for retail traders. This is not investment advice.

Update, 16 November 2026, 21:22 UTC: GraniteShares and Direxion add four more 2X Anthropic funds. GraniteShares ETF Trust’s prospectus, effective on 6 November, covers the GraniteShares 2x Long Anthropic Daily ETF (AIL), which “seeks daily investment results, before fees and expenses, of 2 times (200%) the daily percentage change of the Class A common stock of Anthropic, PBC (Nasdaq: ANT)”, and the GraniteShares 2x Short Anthropic Daily ETF (ANS), which seeks -2 times that daily change. Total annual fund operating expenses are 1.33% for AIL and 2.03% for ANS. In a Form 8-A filed today, the trust says an application to list both funds on Nasdaq “has been filed with and approved by the NASDAQ Stock Market LLC”. On timing, GraniteShares’ fund pages say each fund may begin operations “on or shortly after the first trading day of Anthropic common stock”; a Barchart post on X today said the two funds are expected to launch two trading days after the IPO. Direxion’s prospectus dated 28 October covers the Direxion Daily Anthropic Bull 2X ETF (ANTO) and Direxion Daily Anthropic Bear 2X ETF (ANTD), to be listed on Nasdaq “upon commencement of operations”; the cover gives no start date. Counting the SEC prospectuses we found in an EDGAR full-text search today, at least 15 single-stock Anthropic ETFs from eight fund brands have been registered before ANT’s first trade: 14 leveraged or inverse funds from GraniteShares, Tradr, Direxion, Leverage Shares, ProShares, Defiance and T-REX, plus one YieldMax option-income fund, by our count. A registered prospectus is not a launch, and the leveraged and inverse funds reset daily, so they are not the same as owning Anthropic shares. This is not investment advice.

Update, 16 November 2026, 19:38 UTC: when listed ANT options could start. Under a Cboe rule change filed with the SEC in August 2023 and effective on filing, the usual test that a new stock has traded at $3.00 or more for three business days is waived for a stock with a “market capitalization of at least $3 billion” at its IPO price, and “options on the underlying security may be listed and traded starting on or after the second business day following the initial public offering day”, counted “not inclusive of the day of the IPO”. Anthropic’s base offering alone is $57.75 billion at $70, the bottom of the range, so it clears the $3 billion test, by our arithmetic. If ANT first trades on Thursday, 19 November, the second business day after is Monday, 23 November, the same day Tradr expects ANTT and ANTZ to start trading, by our count. The rule sets the earliest date on which options may list; it does not oblige an exchange to list them that day. This is not investment advice.

Update, 19 November 2026, 02:03 UTC: Reuters reports options could start Monday. “Options on Anthropic shares could begin trading as soon as Monday, giving investors a new way to wager on the AI company’s prospects as market participants expect heavy interest”, Reuters reported (Reuters, post). That matches the earliest date the Cboe rule above allows, Monday, 23 November, the second business day after Thursday’s Nasdaq debut. We read only Reuters’ post and its article summary; the full article was not readable to us. No exchange listing notice for ANT options was published when we checked. This is not investment advice.

Update, 16 November 2026, 18:15 UTC: a 2X leveraged Anthropic ETF now has an expected start date. Tradr ETFs said today that its Tradr 2X Long Anthropic Daily ETF (Cboe: ANTT) and Tradr 2X Short Anthropic Daily ETF (Cboe: ANTZ) “are expected to begin trading on Cboe on Monday, November 23, 2026, the second trading day following the expected initial offering of Anthropic’s common shares on November 19, 2026”. Per its prospectus, effective on filing on 12 November, ANTT “seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of Anthropic”, with total annual fund operating expenses of 1.49%. It gets that exposure through swaps, listed options and/or Anthropic stock and resets daily, so it is not the same as owning Anthropic shares, and the prospectus states the risk plainly: “The return for investors that invest for periods longer or shorter than a single-trading day should not be expected to be 200% of the performance of Anthropic for the period”, and “An investor could lose the full principal value of his/her investment within a single-trading day if Anthropic loses more than 50% in one day”. It adds that “The Fund is not suitable for all investors”. Tradr says the funds are meant to give traders “a jumpstart on leverage in the event ANT options are not yet available”. ANTT and ANTZ are among the 2X Anthropic funds we tracked from their first filings. This is not investment advice.

Update, 16 November 2026, 15:45 UTC: which countries outside the US can buy in the IPO, and where Korea stands. Anthropic’s amended S-1 says the offering “includes public offerings in Australia, Canada, certain member states of the European Economic Area, Japan, Switzerland, and the United Kingdom”. Its Australian filing names the nine EEA states (Germany, Denmark, Finland, France, Ireland, the Netherlands, Norway, Spain and Sweden), so with the US that is 15 countries by our count. Each runs through local channels: in Japan, Rakuten Securities, SBI Securities, Mizuho and others handle a public offering sized at “From 3,000,000,000 U.S. dollars” to $3.5 billion; in Australia, CommSec is “acting as Lead Australian Retail Broker”; in the UK, a retail offer runs through the RetailBook platform, and orders can come from ISA and SIPP accounts; in the EEA, a prospectus approved by Germany’s BaFin covers the offer. Anthropic says it does “not currently intend to list” the shares on any exchange in those countries, and expects retail allocations, US and abroad, of “up to 20%” of the shares offered. South Korea is not on the list. The same filing says the shares “will not be registered” under Korea’s capital markets law and are offered there only “as a private placement”. The Korea Herald reported on 4 November that “None of the 22 financial institutions named in Anthropic’s filing is a Korean brokerage”, which could leave Korean retail investors without direct access. This is not investment advice.

Update, 16 November 2026, 13:45 UTC: a Canadian-dollar route to Anthropic. CIBC said on 16 November that it intends to list an Anthropic Canadian Depositary Receipt (CDR) on the Toronto Stock Exchange under the ticker ANTH, “with trading expected to begin on November 19, 2026”, the day Anthropic’s own shares are expected to start trading on Nasdaq. The listing is labelled “CAD Hedged”. CIBC says CDRs are “offered at a fraction of the price per share of the underlying reference share” and come “with a built-in notional currency hedge”, trading in Canadian dollars. The release does not give the ratio of CDRs to Anthropic shares; it says the prospectus supplement has been filed on SEDAR+. Elliot Scherer of CIBC Capital Markets called it “another way to get exposure to Anthropic” for Canadians. With Anthropic, CIBC says it will offer 146 CDRs across six countries. This is not investment advice.

Update, 15 November 2026: where Bloomberg’s $90.4 billion comes from. In a feature on 15 November, Bloomberg called Anthropic’s listing “what is expected to be the largest ever IPO”, and its own social post put the raise at “as much as $90.4 billion in an IPO and private placement”. That figure matches the top of the filed range plus the side deal: 825,000,000 shares at $78 is $64.35 billion, and adding the $26.0 billion Class N private placement gives $90.35 billion, about $90.4 billion, by our arithmetic.

On that reading, it includes the 23,648,646 shares sold by existing holders, about $1.84 billion at $78, from which Anthropic receives no proceeds, and it leaves out the underwriters’ option on 123,750,000 more shares. With that option exercised at $78, the public offering is $74.0 billion and the total with the placement $100.0 billion; at the $74 midpoint, the base deal plus the placement is $87.05 billion, by our arithmetic. The S-1/A estimates Anthropic’s own net proceeds from the offering and the placement at approximately $84.6 billion at $74, or approximately $93.7 billion if the option is exercised in full. The figures in this guide are unchanged.

Update, 15 November 2026: demand near seven times. In a feature published at 19:00 UTC on 15 November, Bloomberg reported that the IPO “has drawn orders for close to seven times the shares available”, citing people familiar with the matter; on 12 November it had reported about six times. On the 825,000,000 shares offered, that is just under 5.8 billion shares of orders, or up to about $404 billion to $450 billion at the $70 to $78 range, by our arithmetic. One of the people said demand is much hotter than it was for SpaceX at the same point in the process. Bloomberg also reported that bankers at Goldman Sachs and Morgan Stanley, which lead the deal, are expected to stop taking orders on Tuesday, 17 November, the day of Nvidia’s results, and a Bloomberg Intelligence analyst estimated the company could enter the Nasdaq 100 within about three weeks of listing if its valuation holds. A representative for Anthropic declined to comment. The figures in this guide are unchanged.

Anthropic’s roadshow release of 10 November repeats the share count, the range and the ANT symbol. Our Anthropic IPO map tracks every filing and report since the first S-1.

Anthropic’s implied value at the bottom, midpoint and top of its $70 to $78 range, on the 13,086,672,593
Anthropic’s implied value at the bottom, midpoint and top of its $70 to $78 range, on the 13,086,672,593 shares of all classes the S-1/A says will be outstanding after the offering; tags show the cost of Fidelity’s 25-share minimum request. Values and costs are our arithmetic.

Business Pill · IPO float

An evergreen Business Engineer explainer on IPO float: the share of a company that trades after a listing. It teaches the general idea only and does not discuss Anthropic’s listing.

The key insight: As we read the filing, there are two ways in: a request at the IPO price through one of six named platforms, each with its own eligibility rules and no guarantee of shares, or a market order on Nasdaq once ANT trades on 19 November, the date Anthropic’s IPO website expects. At Fidelity’s 25-share minimum the first route costs $1,750 to $1,950, by our arithmetic.

How to Request Shares at the IPO Price

The filing says a portion of the shares will, at Anthropic’s request, be offered to retail investors through Charles Schwab, Fidelity, Robinhood, Trade-PMR, SoFi and E*TRADE from Morgan Stanley. “These platforms will act as selling group members for this offering”, it says.

It adds: “Any purchase of our Class A common stock in this offering through these platforms will be at the initial public offering price”. Purchases are subject to each platform’s own terms, conditions and requirements.

The IPO website Anthropic filed with the SEC describes the process in its FAQ: “You can request shares through a participating brokerage platform”. You need an active account and must submit an indication of interest, which is a request, not a purchase.

The same FAQ warns: “There is no guarantee that any investor will receive all or any of the shares they apply for in the Anthropic IPO”. In aggregate the filing expects retail allocations, in the US and other countries, of “up to 20% of the shares of Class A common stock offered pursuant to this prospectus”; our retail allocation piece sizes that ceiling.

What Fidelity, Robinhood and SoFi Say

Fidelity’s Anthropic page, dated 10 November, says the offer period closes at 4:00 PM ET on Tuesday, 17 November, and that the offering is expected to be priced the evening of Wednesday, 18 November. “Fidelity customers with at least $25,000 in certain assets at Fidelity may be eligible to participate”, it says.

Requests at Fidelity run from a 25-share minimum, in 25-share increments, to a maximum of 1,000,000 shares. Customers must confirm the request on the night of pricing, usually after 7:00 p.m. ET, and Fidelity says allocation is usually complete before 9:30 a.m. ET the next morning.

Payment is due by settlement, usually one business day after the trade. Fidelity applies a 15-calendar-day tracking period: selling within it counts as flipping, and repeat flipping restricts access to its future IPOs for 6 months, then 1 year, then permanently.

Robinhood’s general IPO Access page, which does not name Anthropic, says retirement, joint, custodial and managed accounts are not eligible and that requests need 100% buying power. It says “Selling within 30 days of the IPO counts as flipping, and may block you from IPO Access for 60 days”.

SoFi’s IPO page carries the line “Anthropic IPO is now available at SoFi.” We did not read Anthropic-specific terms from Schwab, Trade-PMR or E*TRADE; Schwab’s IPO page sits behind a client log-in.

What You Pay at $70, $74 and $78

At Fidelity’s 25-share minimum, a filled request costs $1,750 at $70, $1,850 at the $74 midpoint and $1,950 at $78, by our arithmetic. One hundred shares cost $7,000 to $7,800.

The filing says 13,086,672,593 shares of all classes will be outstanding after the offering and the private placement. At $70, $74 and $78, that values Anthropic at $916.1 billion, $968.4 billion and $1,020.8 billion, by our arithmetic. Our price-to-sales piece compares those values with Nvidia and Palantir.

Buying After It Starts Trading

Anyone without an IPO allocation can buy ANT on Nasdaq once it trades, through any brokerage that offers Nasdaq stocks. The IPO website FAQ draws the line: “Shares bought after Anthropic starts trading will be purchased at the prevailing market price at that time”.

The filing says up to 316 million shares of Class A common stock may become eligible for sale beginning on the first trading day after the prospectus date. That is 38% of the 825,000,000 IPO shares, by our arithmetic.

Update, 16 November 2026, 21:42 UTC: MSCI names 30 November as the earliest index date. In an index announcement at 21:16 GMT today, MSCI said that if Anthropic’s first trading day is 19 November, as expected by Nasdaq, then, “subject to Anthropic meeting the criteria for an early inclusion”, the inclusion in the MSCI Global Investable Market Indexes “would be implemented as of the close of November 30, 2026 (effective December 01, 2026)”, alongside its November 2026 Index Review. Its 12 November notice sets the test: a full market capitalisation of at least 1.8 times the Interim Market Size-Segment Cutoff, and a free float-adjusted market capitalisation of at least 1.8 times one-half of that cutoff, “as of the close of its first or second trading day”. MSCI announces an early inclusion no later than before the opening of the third trading day. The standard rule puts an early inclusion at the close of the tenth trading day, which would be 3 December counting from 19 November with the 26 November Thanksgiving closure, by our count; MSCI says inclusions falling within “5 days before the effective date of a regularly scheduled Index Review or 3 days after” are moved to coincide with that review. The caveat about missing data, reported on X today, applies in MSCI’s text to its factor, thematic, sustainability and climate indexes whose review results are due on 18 November: there, “other index rules may lead to ineligibility because of a lack of required datapoints for a newly public company”, so inclusion “may be a matter for a subsequent scheduled Index Review”. Capped indexes such as the MSCI 10/40 Indexes, and the Value and Growth Indexes, typically add large IPOs at the same time as the main indexes, MSCI said. MSCI has not said Anthropic meets the size test; that depends on its market value at the close of its first or second trading day. This is not investment advice.

Update, 17 November 2026, 00:07 UTC: on the index providers’ own rules, Anthropic would join the Nasdaq-100 later than SpaceX did, and the S&P 500 is at least a year away. Bloomberg reported at 23:06 UTC on 16 November under the headline “Anthropic Faces a Longer Wait Than SpaceX to Join Stock Indexes”. The article is paywalled and we could not read it, so what follows is our reading of the index rules, not Bloomberg’s account.

Nasdaq-100. Nasdaq’s Fast Entry rule ranks a new listing “as of the end of its seventh trading day” and, if its full market capitalisation ranks within the top 40 index members, typically adds it “after 15 trading days”. That is how SpaceX, which first traded on 12 June, joined “prior to market open on Tuesday, July 7, 2026”, according to Nasdaq’s 26 June release. But “Where the 15th trading day falls within the same calendar month as a scheduled index reconstitution or rebalance”, the timing changes. Counting from a 19 November debut, with 26 November closed, Anthropic’s seventh trading day would be Monday 30 November, the last trading day of November and the reference date of the annual December reconstitution, and its 15th trading day would be 10 December, by our count. A security whose seventh day “falls on or before the Reconstitution or Rebalance Reference Date” is “added to the Index as part of the reconstitution or rebalance”, which takes effect “At market open on the first trading day following the third Friday in December”: Monday 21 December, after 21 trading days rather than SpaceX’s 15, by our reading, and only if Anthropic ranks within the top 40 and meets the other criteria. Nasdaq announces reconstitution changes “After the close on the sixth trading day prior to” the effective date, 11 December by our count. MSCI’s earliest date, the 30 November close, is in the box above.

S&P 500. The S&P U.S. Indices Methodology says IPOs “should be traded on an eligible exchange for at least 12 months before being considered” and “There is no IPO fast track entry allowed for S&P Composite 1500 candidates”, a group that includes the S&P 500. It also requires that GAAP net income from continuing operations “must be positive for” both the most recent quarter and the sum of the most recent four consecutive quarters. Anthropic’s S-1/A Amendment No. 2 shows a net loss in each of the last four reported quarters: $16.9 billion, $14.4 billion, $66.3 billion and $23.3 billion for the quarters to December 2025, March, June and September 2026, or $120.9 billion in total by our sum, of which $108.5 billion came from changes in the fair value of convertible notes, derivative liabilities and SAFEs. On our reading of the methodology, Anthropic could not be considered for the S&P 500 before November 2027, and not until its GAAP results are positive on both tests. Index committees decide additions; this is not investment advice.

Update, 17 November 2026, 03:22 UTC: on FTSE Russell’s own rules, Anthropic could join the Russell 1000 after the close on 25 November, by our reading, weeks before the Nasdaq-100 date above. GuruFocus reported at 02:30 UTC under the headline “Anthropic’s IPO May Attract Billions Ahead of Russell 1000 Inclusion”. We could not read the article, so we do not use its estimate; what follows is our reading of the Russell US Equity Indexes methodology (v7.4, November 2026).

Fast entry. IPOs whose investable market capitalisation exceeds the market-adjusted Russell Top 500 breakpoint are eligible, and “Eligible fast entry IPOs will be added after the close of the fifth day of trading following the initial listing (FTSE Russell will provide notice confirming effective date).” FTSE Russell calls it “fast entry on day five”. Counting a 19 November debut as day one, with markets closed on 26 November, the fifth day is Wednesday 25 November, by our count. The size test uses “the shares offered in the IPO and the price at market close on the first trading day”, and greenshoe and locked-up shares are excluded from the index, so Anthropic would enter at the weight of its 825,000,000 offered shares, not its full value, by our reading.

Conditions. “Fast entry IPOs must be fully guaranteed (i.e. underwritten)”; the filing names Goldman Sachs and Morgan Stanley as representatives of the underwriters. Companies normally need at least 5% of shares in free float and 5% of voting rights with unrestricted holders, but a fast entry IPO may be added below either if locked-up shares expiring within 12 months are expected to lift it over the minimum; Anthropic’s insider lock-ups end no later than the 180th day (about 2.7 billion shares) and the 365th day (the co-founders and about 8.0 billion shares) after the prospectus date, as the guide notes above. Fast entry IPOs whose effective date falls in a lock-down are “implemented in conjunction with the scheduled rebalance”; FTSE Russell’s December schedule starts the lock-down on Monday 30 November, with the reconstitution taking effect after the close on 11 December. FTSE Russell confirms each fast entry date by notice; we found none naming Anthropic at the time of writing. Index decisions rest with FTSE Russell; this is not investment advice.

Correction, 18 November 2026, 00:39 UTC: FTSE Russell’s notice sets 11 December, not 25 November. Our 17 November update above said Anthropic could join the Russell 1000 after the close on 25 November, by our reading, and that we had found no FTSE Russell notice naming Anthropic. That was wrong. An FTSE Russell notice dated 13 November says that, because a first trading day on 19 or 20 November would put the inclusion date close to Thanksgiving, Anthropic “will be added in conjunction with the December semi-annual reconstitution, after the close of business on Friday 11 December 2026 (effective from market open on Monday 14 December 2026), if Anthropic meets the fast entry criteria”. The notice puts the fast entry threshold at “US$17.942 billion (investable market capitalization)” and says FTSE Russell will confirm eligibility after the first day of trading. The Nasdaq-100 date above, 21 December, is unchanged. Details: our index-dates piece. Not investment advice.

Which Shares You Get

IPO buyers get Class A common stock. The filing says each Class A share is entitled to one vote, while Class N shares have no voting rights except as otherwise required by law; our non-voting stock explainer covers Class N.

A single Class F share, held by a company organised by the seven co-founders, will carry votes equal to 50.1% of the total voting power on matters put to stockholders generally, the filing says. The 825,000,000 IPO shares are 6.3% of all shares outstanding after the deal, by our arithmetic.

Insiders face lock-ups. Non-founder directors, officers, employees and holders of about 2.7 billion shares are restricted until the earlier of the second full trading day after the first-quarter 2027 results and the 180th day after the prospectus date.

The seven co-founders and holders of about 8.0 billion shares are restricted until the earlier of the second full trading day after results for the quarter ending 30 September 2027 and the 365th day. The Class N shares sold in the private placement are not subject to the underwriters’ lock-up but are restricted securities, the filing says.

Stacked bar: of 13.09 billion Anthropic shares outstanding after the IPO, 825 million IPO shares are 6.3%, other Class A 6.60 billion or 50.5%, Class N 5.66 billion or 43.2%, per the S-1/A
Shares outstanding after the IPO and the concurrent private placement, from Anthropic’s S-1/A No. 2 counts (7,427,991,791 Class A including the 825,000,000 IPO shares; 5,658,680,800 Class N). Percentages are our arithmetic; the single Class T and Class F shares are omitted.

When Does Anthropic Start Trading?

The IPO website says: “Subject to regulatory clearance, the final IPO share price is expected to be set on November 18th (EST), and shares are expected to begin publicly trading on November 19th (EST)”. Our day-by-day guide lists each step.

What Is Anthropic’s Stock Ticker?

ANT, on the Nasdaq Global Select Market, for the Class A common stock, according to the S-1/A and the roadshow release.

Update, 19 November 2026, 05:39 UTC: the retail squeeze. The Financial Times reports that “Anthropic retail investors face squeeze in blockbuster IPO”, adding that the “Frenzy for AI stocks is testing how far Wall Street will go to accommodate a new army of individual investors” (FT). We could read only the headline and summary, not the article. Anthropic’s own prospectus lists among the factors that could move its share price the “potential allocation to retail investors of a minority of shares of our Class A common stock sold in this offering”. The passage we reviewed does not give the size of that retail allocation, so we cannot say how many times it was covered. For scale, CNBC reported, citing people who asked not to be named, that retail demand was “approaching $100 billion” (CNBC); that figure is about 1.2 times the roughly $81.3 billion raised by the whole 980 million-share offering at $83, by our arithmetic. Not investment advice.

Update, 19 November 2026, 07:32 UTC: According to the Financial Times, as summarised by Techmeme, “Sources expect Anthropic’s IPO allocation for retail investors to fall below 20%”, and “retail buyers have historically received 5% to 10% of shares in large IPOs”. By our arithmetic, below 20% of the 980 million shares offered means fewer than about 196 million shares, or under about $16.3 billion at $83. Also by our arithmetic, if CNBC’s report is right that retail demand was “approaching $100 billion” (CNBC, citing people who asked not to be named), that demand would be roughly six times the expected ceiling on the retail allocation. Not investment advice.

Update, 19 November 2026, 13:42 UTC: selling IPO shares fast can cost you future allocations. Investors who flip Anthropic stock may face penalties from their broker, CNBC reported on the morning of the debut. This is not investment advice.

Fidelity applies restrictions if shares are sold within the first 15 calendar days of secondary trading, CNBC said. A first flip blocks IPO participation for six months, a second for one year and a third brings a permanent ban.

Robinhood counts a sale within 30 days as flipping; such investors “may be prevented from participating in IPO access for 60 days.” SoFi says selling within 30 calendar days “may affect your ability to participate in future IPOs on SoFi.”

E*Trade “prefers investors hold shares for at least 30 calendar days” and may weigh early sales in future eligibility, CNBC said. Charles Schwab “does not apply a flipping restriction” unless an issuer requires one, a spokesperson said, adding this is subject to change.

Check your broker’s terms before selling. Follow the debut in our live blog.

Update, 19 November 2026, 11:06 UTC: how much European retail investors got. Anthropic sold $1.1 billion of IPO stock to retail investors in the UK and continental Europe, Bloomberg reported, citing regulatory filings it reviewed.

UK buyers took just over 3.6 million shares, about $300 million at the $83 IPO price (our arithmetic). RetailBook coordinated the UK offer, and AJ Bell, Hargreaves Lansdown and Revolut were among the firms taking orders, Bloomberg said.

RetailBook operates the public offer platform under FCA rules, Anthropic’s UK offer materials say. Buyers in the EU, Norway and Switzerland took close to 9.7 million shares, about $800 million at $83 (our arithmetic), according to Bloomberg.

Trade Republic and Saxo Bank were among the continental brokers, and BNP Paribas, Deutsche Bank and UBS among the banks arranging the offer, Bloomberg said. The offer ran on a BaFin-approved prospectus, also used for the Swiss offer, with a ceiling of 80,135,135 shares.

Close to 9.7 million shares is about 12% of that ceiling (our arithmetic). The prospectus expected the offer period to close on or about 18 November; the shares debut in New York later today, Bloomberg said. Our piece on the allocations.

Can Retail Investors Buy at the IPO Price?

Yes, through the six named platforms, subject to each one’s eligibility rules and allocation. The filing says those purchases will be at the IPO price; getting shares is not guaranteed.

Update, 17 November 2026, 14:40 UTC: pricing guidance. Bloomberg reported that Anthropic is said to guide its IPO price to the top of its $70 to $78 range or above, and CNBC reported, citing multiple sources, that it is likely to price above the range; CNBC said order books close at 4 p.m. ET on Tuesday. Our piece sets out what $78 and an illustrative $85.80 mean on the prospectus share count. Not investment advice.

Update, 17 November 2026, 14:45 UTC: UK investors. This is Money reported on 17 November that Britons have until Wednesday to apply for a minimum of £250 of shares in the IPO through platforms such as AJ Bell and Hargreaves Lansdown, and that UK investors “could miss out on a full allocation”. It cited the SpaceX listing: £750 million of orders from the UK, of which £217 million of shares were allocated, with two in five investors missing out on their full allocation; anyone who applied for £2,013 or less received the full amount, and a cap of 1,000 shares applied. That SpaceX fill rate was 28.9% of the money ordered, by our arithmetic. The article does not say how Anthropic’s UK shares will be allocated, and the platforms’ terms may differ. This is Money. Not investment advice.

How Many Shares Are Being Sold?

825,000,000 Class A shares, with an option for 123,750,000 more. Retail allocations are expected to be up to 20% of the offered shares, though final amounts depend on demand, the filing says.

What Is the Anthropic Lock-Up?

For most insiders, up to 180 days or until shortly after the first-quarter 2027 results; for the co-founders and some large holders, up to 365 days. Goldman Sachs and Morgan Stanley may release shares early, the filing says. Our explainer on how the Anthropic IPO works sets out the full release calendar.

The Structural Read

As we read the broker pages, the rules differ by platform: Fidelity ties eligibility to $25,000 of assets and tracks flipping for 15 days, while Robinhood’s general IPO Access page excludes retirement and joint accounts and counts sales within 30 days as flipping.

As we read the share table, IPO buyers get Class A stock with one vote a share, but the 825,000,000 IPO shares are 6.3% of the 13,086,672,593 shares outstanding after the deal, by our arithmetic, and a single Class F share carries 50.1% of the voting power, the filing says.

Anthropic, PBC, IPO website FAQ (filed with the SEC)

“Shares bought in the IPO will be purchased at the offering price, which is expected to be set on November 18th (EST).”

Three Implications

FOR IPO REQUESTS Fidelity’s page says its offer period closes at 4:00 PM ET on Tuesday, 17 November, and requests must be confirmed on pricing night.

FOR BUYING AFTER LISTING The IPO website says shares bought after trading starts are purchased at the prevailing market price; up to 316 million other shares may be sellable from day one, the filing says.

FOR INSIDERS’ SHARES Lock-ups run up to 180 days for most insiders and up to 365 days for the co-founders and some large holders, per the filing.

The Business Engineer Lens

This story maps onto the Business Engineer framework The AI Supercycle.

The framework states: “For that reason, the AI Supercycle is not a forecast. It is a structure.”

As we read it, this guide works the same way: it maps the structure of the offering, the share classes, the platforms and the dates, and makes no forecast of the price; the framework was published before the IPO and does not discuss this listing.

What Is Not Established

The final price is not set and can fall outside the filed range, and the dates are subject to regulatory clearance. How many shares each platform receives, and how each allocates them, is not established.

This piece describes how the offering works; it is not a forecast of where ANT will trade and not a recommendation. Anthropic and the brokers were not contacted for this piece.

This Week In The AI Supercycle

AI Lost Its Central Banker, the Lab Oligopoly, and the Future of Open Source

This week’s issue: the Nvidia leadership change, read as the AI build-out losing its central banker: who now finances the GPU landlords, backstops the data centres and sponsors open models, and why two labs are becoming the bank.

Read the full issue →

Business Engineer Framework

Anthropic’s S-1 & The State of Frontier AI

The Business Engineer premium analysis of Anthropic’s S-1: how the business makes money and what it commits to spend.

Read the Map of AI →

More on this

Anthropic IPO, every angle

Our 110 pieces on the listing, newest first in each group. Not investment advice.

Latest: S-1/A No. 3 and pricing week (10)
Who owns what, and who gains (26)
How to buy, retail access and index entry (19)
Valuation, analysts and markets (27)
Terms, filings and timing (28)

The Bottom Line

Anthropic’s 825,000,000 Class A shares are offered at $70.00 to $78.00, to list on Nasdaq as ANT, with pricing expected on 18 November and trading on 19 November. Retail requests go through six named platforms; Fidelity’s 25-share minimum costs $1,750 to $1,950, by our arithmetic.

Important: not investment advice

This article is for information and education only. It is not investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy or sell any security, ETF, option or other financial product. FourWeekMBA is not a broker-dealer or a registered investment adviser. IPO shares, leveraged and inverse ETFs, and options carry significant risk, including the loss of your entire investment; leveraged and inverse ETFs reset daily and can lose value quickly. Prices, availability, fees and eligibility change and can differ by country and broker, so check the prospectus and your broker’s terms. Figures marked “our arithmetic” are our own calculations from the cited filings and may contain errors. Do your own research and consider speaking to a licensed financial professional before making any investment decision.

95,000+ executives read Business Engineer for the AI strategy frameworks cited by ChatGPT, Claude, and Perplexity.

A note on sourcing. We read Anthropic’s Amendment No. 2 to Form S-1 of 10 November 2026 and the IPO-website free writing prospectus it filed on SEC EDGAR, plus its roadshow release. Broker terms come from Fidelity’s Anthropic IPO page, Robinhood’s IPO Access support page and SoFi’s IPO page, each read on 15 November 2026 and attributed to that broker. Company values and order costs are our arithmetic. Nothing here is investment advice. Anthropic and the brokers were not contacted for this piece.

Update, 18 November 2026, 21:35 UTC: the reported IPO price is $83. Bloomberg reported that Anthropic “Is Said to Price IPO at $83 Per Share”, citing people familiar with the matter; Anthropic had not filed its final prospectus on EDGAR when we checked at 21:19 UTC. $83 is 6.4% above the $78 top of the $70 to $78 range Anthropic set when it launched its roadshow on 10 November. On the 13,086,672,593 shares the S-1/A lists as outstanding after the offering, $83 is about $1.09 trillion, and 825,000,000 shares sold raise about $68.5 billion before the underwriters’ option (our arithmetic). Wall St Engine, relaying the report, put the valuation at $1.5 trillion; the report as relayed does not give the share base behind that figure. Anthropic said when it launched its roadshow that it would list on Nasdaq under ANT. Full report: Anthropic Set to Price IPO at $83 a Share, Bloomberg Says. Not investment advice.

Update, 18 November 2026, 22:05 UTC: WSJ and CNBC report the $83 pricing. The Wall Street Journal reported that “Anthropic priced its IPO at $83 a share, above the expected range, and sold more shares than planned” (WSJ); CNBC reported the same price, citing a source. Full report: Anthropic Prices IPO at $83 a Share, Above Range, WSJ Says. Not investment advice.

Official, 18 November 2026, 23:37 UTC: Anthropic priced at $83. Anthropic said it “priced its initial public offering of its Class A common stock at $83.00 per share”, selling 980,000,000 shares (956,351,354 by Anthropic), about $81.34B at that price (our arithmetic). Trading is expected on the Nasdaq Global Select Market on 19 November under the symbol ANT. Full report: Anthropic Prices IPO at $83, Selling 980M Shares for $81.3B. Not investment advice.

Sources: FTSE Russell notice, 13 Nov 2026 · Anthropic, PBC: Amendment No. 2 to Form S-1 (SEC EDGAR, 10 Nov 2026) · Anthropic, PBC: IPO website free writing prospectus (SEC EDGAR) · Anthropic: roadshow launch release (10 Nov 2026) · Fidelity: How to participate in the Anthropic IPO · Robinhood: About IPO Access · SoFi: IPO investing

Scroll to Top
FourWeekMBA